Twitter Blue tweet may have cost Eli Lilly $LLY billions due to price of insulin

[IbogaProject]

21. Barriers to entry

Insulin first discovered in the late 1920s. Only advances over 50 years was different suspensions which slowed the absorption. The next advance was using biotech with recombining DNA altered eco-li cells those human insulins went on the market in 1982. The technology hasn't matured much. The most recent changes were Humalog, Novalog both made with one pair of amino acids switched. Those are made exactly the same as the prior ones. The other advance was hanging stuff off the molecule to get the absorption to right around 24 hours and stable absorption. There are two main types Glaglarine and Detmir.
The small cartel of basically three companies have the regulatory bodies have much harder approval than the previous generic drug regulations. So now the two biggest of the cartel each make a bio-similar (identical) of another's product to offer very slight discounts on things that should be under free market competition with only safety regulations constraining them.
The problems we face in getting a single national health payment system are the campaign cash big pharma throws around, and their huge advertising budgets corrupting journalism.
Single payer would save everyone aggravation, reduce delays to care, save money even during the initial transition. There would then be knock on benefits like reducing liability insurance, since health costs wouldn't have to be covered anymore and again no barriers to diagnosis and treatment.